gadolinium has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 25 (39.68) | 29.6817 |
2010's | 35 (55.56) | 24.3611 |
2020's | 3 (4.76) | 2.80 |
Authors | Studies |
---|---|
Bauer, H; Ebert, W; Griesinger, C; Misselwitz, B; Mühler, A; Schmitt-Willich, H; Weinmann, HJ | 1 |
Eisenwiener, KP; Mäcke, HR; Merbach, AE; Nicolle, GM; Tóth, E | 1 |
Aasen, AJ; Hovland, R; Klaveness, J | 1 |
Allen, MJ; Meade, TJ | 1 |
Ebron, VH; Sherry, AD; Woods, M; Zhang, S | 1 |
Lenkinski, RE; Merritt, M; Sherry, AD; Woessner, DE; Zhang, S | 1 |
Kovacs, Z; Sherry, AD; Woods, M; Zhang, S | 1 |
Anelli, PL; Lattuada, L; Lorusso, V; Lux, G; Morisetti, A; Morosini, P; Serleti, M; Uggeri, F | 1 |
Aplincourt, M; Guillon, E; Moreau, J; Pierrard, JC; Port, M; Rimbault, J | 1 |
Aime, S; Hermann, P; Kotek, J; Lukes, I; Mainero, V; Rudovský, J | 1 |
Aime, S; Botta, M; Hermann, P; Lukes, I; Rudovsky, J | 1 |
Cannara, RJ; Casalbore, P; Crawford, JF; Daniels, MJ; De Stasio, G; Erhardt, RJ; Fowler, JF; Frazer, BH; Gilbert, B; Gilles, MK; Howard, SP; Larocca, LM; Mehta, MP; Mercanti, D; Pallini, R; Rajesh, D; Richter, KL; Schaub, S; Sonderegger, BR; Tyliszczak, T; Wiese, LM | 1 |
Hermann, P; Kolar, ZI; Kotek, J; Kubícek, V; Lukes, I; Muller, RN; Peters, JA; Rudovský, J; Vander Elst, L; Wolterbeek, HT | 1 |
Aime, S; Botta, M; Hermann, P; Koridze, A; Rudovský, J | 1 |
Benmelouka, M; Borel, A; Brunel, LC; Helm, L; Merbach, AE; Port, M; Van Tol, J | 1 |
Aime, S; Barge, A; Belfiore, S; Cabella, C; Forni, G; Geninatti Crich, S; Ghirelli, C; Lanzardo, S; Lattuada, L; Mortillaro, A; Tei, L; Visigalli, M | 1 |
Comuzzi, C; Overhand, M; Prudêncio, M; Ubbink, M; van den Nieuwendijk, AM; Vlasie, MD | 1 |
Binnemans, K; Helm, L; Hermann, P; Kotek, J; Lebdusková, P; Lukes, I; Merbach, AE; Rudovský, J; Tóth, E | 1 |
Brücher, E; Caravan, P; Jurek, P; Kalman, FK; Kiraly, R; Sherry, AD; Spiller, M; Tircsó, G; Woods, M | 1 |
Brown, S; Finn, MG; Manchester, M; Prasuhn, DE; Singh, P; Strable, E | 1 |
Breeman, WA; Elst, LV; Hermann, P; Kolar, ZI; Kubícek, V; Lukes, I; Muller, RN; Peters, JA; Vitha, T; Wolterbeek, HT | 1 |
Hermann, P; Kotek, J; Lukes, I; Muller, RN; Polásek, M; Sedinová, M; Vander Elst, L | 1 |
Kawano, K; Maitani, Y; Minowa, T; Shiraishi, K; Yokoyama, M | 1 |
Hermann, P; Kotek, J; Kubícek, V; Lukes, I; Muller, RN; Peters, JA; Vander Elst, L; Vitha, T | 1 |
Baranyai, Z; Botta, M; Gugliotta, G; Tei, L | 1 |
Heckl, S; Sturzu, A | 1 |
Botta, M; Kielar, F; Tei, L; Terreno, E | 1 |
Angelovski, G; Logothetis, NK; Mamedov, I; Parac-Vogt, TN | 1 |
Gokhale, V; Guntle, GP; Jagadish, B; Mash, EA; Nichol, GS; Raghunand, N | 1 |
Chang, Y; Gu, S; Kang, BS; Kim, HK; Kim, TJ; Lee, GH | 1 |
Chang, HW; Chen, KJ; Durazo, A; Garcia, MA; Hsu, CH; Hwang, LP; Jiang, ZK; Lin, YY; Tseng, HR; Wang, H; Wolahan, SM; Wu, L | 1 |
Bell, JD; Bunch, J; Higham, SA; Kalber, TL; Kamaly, N; McLeod, CW; Miller, AD; Pugh, JA | 1 |
Lu, Y; Xu, W | 1 |
Cosconati, S; Demmer, O; Dijkgraaf, I; Gourni, E; Kessler, H; Marinelli, L; Schumacher, U; Wester, HJ | 1 |
Chordia, MD; Kundu, B; Pan, D; Xiao, L; Xu, Y; Yang, Z; Zhang, Y | 1 |
Webber, BC; Woods, M | 1 |
Helm, L; Hermann, P; Kotek, J; Kotková, Z; Lukeš, I | 1 |
Davies, GL; Davis, JJ; Huang, WY | 1 |
Gavins, FN; Long, NJ; Luthra, SK; Morisson Iveson, V; Smith, H; Stasiuk, GJ; Tremoleda, JL; Trigg, W; Wylezinska-Arridge, M | 1 |
Aime, S; Alberti, D; Djanashvili, K; Geninatti Crich, S; Szabo, I | 1 |
Arrais, A; Botta, M; Carniato, F; Marchese, L; Tei, L | 1 |
Baek, KH; Shin, I; Tian, X | 1 |
Allard, M; Ishar, MP; Kaul, A; Mishra, AK; Saini, N; Tiwari, AK; Varshney, R | 1 |
Cai, Q; Goswami, LN; Hawthorne, MF; Jalisatgi, SS; Ma, L; Sarma, SJ | 1 |
Bordignon, E; Brooks, EK; Garbuio, L; Hubbell, WL; Jeschke, G; Yulikov, M | 1 |
Antoine, R; Besse, S; Chezal, JM; Dugourd, P; Janier, M; Kryza, D; Lux, F; Mignot, A; Miot-Noirault, E; Morlieras, J; Perriat, P; Redini, F; Sancey, L; Tillement, O; Truillet, C; Vidal, A | 1 |
Bharucha, AE; Fauq, AH; Maharvi, GM | 1 |
Engelbogen, N; Havlíčková, J; Herdtweck, E; Hermann, P; Kapp, TG; Kessler, H; Notni, J; Šimeček, J; Wester, HJ | 1 |
Dregely, I; Hermann, P; Notni, J; Wester, HJ | 1 |
Ahrén, M; Engström, M; Hu, Z; Selegård, L; Skoglund, C; Söderlind, F; Uvdal, K; Zhang, X | 1 |
Deeg, M; Echner, H; Ernemann, U; Heckl, S; Kalbacher, H; Klose, U; Nägele, T; Schwentner, C; Sheikh, S; Sturzu, A | 1 |
Cescato, R; Gmeiner, P; Hübner, H; Kolesinska, B; Maschauer, S; Prante, O; Purkayastha, N; Reubi, JC; Seebach, D; Sparr, C; Waser, B; Yoshinari, T | 1 |
Boros, E; Caravan, P; Helm, L; Karimi, S; Kenton, N | 1 |
Kempen, P; Lin, J; Pandit, P; Rao, J; Rutt, B; Sinclair, R; Xiong, L; Ye, D | 1 |
Conti, PS; Hu, H; Li, D; Li, Z; Liu, S; Moats, R; Wang, M | 1 |
Affolter-Zbaraszczuk, C; Barthès, J; Baumert, TF; Caruso, F; Cui, J; Mertz, D; Meyer, F; Ogier, J; Voegel, JC | 1 |
Aulsebrook, ML; Gasser, G; Grace, MR; Graham, B; O'Malley, WI; Rubbiani, R; Spiccia, L; Tuck, KL | 1 |
Aboagye, EO; Carroll, L; Cowell, S; Lavdas, I; Vilar, R | 1 |
Jin, Y; Tian, J; Wang, K | 1 |
Klajnert-Maculewicz, B; Liu, J; Peng, C; Shen, M; Shi, X; Xiong, Z; Zhang, J | 1 |
Clark, HA; Seo, H | 1 |
Aid-Launais, R; Chaubet, F; Chauvierre, C; Forero Ramirez, LM; Gobin, E; Journe, C; Le Cerf, D; Letourneur, D; Moraes, FC; Picton, L | 1 |
Andersen, HOB; Storm Thomsen, M; Sørensen, TJ | 1 |
1 review(s) available for gadolinium and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Article | Year |
---|---|
PARACEST agents: modulating MRI contrast via water proton exchange.
Topics: Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Lanthanum; Ligands; Magnetic Resonance Imaging; Models, Theoretical; Molecular Structure; Protons; Water | 2003 |
62 other study(ies) available for gadolinium and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Article | Year |
---|---|
Early distribution dynamics of polymeric magnetic resonance imaging contrast agents in rats.
Topics: Animals; Contrast Media; Dysprosium; Europium; Extravasation of Diagnostic and Therapeutic Materials; Gadolinium; Half-Life; Heterocyclic Compounds, 1-Ring; Kidney; Magnetic Resonance Imaging; Male; Molecular Weight; Rats; Rats, Wistar; Ytterbium | 2002 |
From monomers to micelles: investigation of the parameters influencing proton relaxivity.
Topics: Algorithms; Chemical Phenomena; Chemistry, Physical; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Indicators and Reagents; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Micelles; Molecular Conformation; Oxygen Isotopes; Protons; Surface-Active Agents | 2002 |
Preparation and in vitro evaluation of GdDOTA-(BOM)4; a novel angiographic MRI contrast agent.
Topics: Angiography; Animals; Cattle; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Protein Binding; Serum Albumin, Bovine | 2003 |
Synthesis and visualization of a membrane-permeable MRI contrast agent.
Topics: 3T3 Cells; Animals; Cell Membrane Permeability; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Magnetic Resonance Imaging; Mice; Microscopy, Confocal; Peptides | 2003 |
pH-sensitive modulation of the second hydration sphere in lanthanide(III) tetraamide-DOTA complexes: a novel approach to smart MR contrast media.
Topics: Amides; Contrast Media; Electrochemistry; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Hydrogen-Ion Concentration; Kinetics; Luminescent Measurements; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Organometallic Compounds; Oxidation-Reduction; Protons; Pyridines; Water | 2003 |
Towards the rational design of magnetic resonance imaging contrast agents: isolation of the two coordination isomers of lanthanide DOTA-type complexes.
Topics: Contrast Media; Drug Design; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Isomerism; Lanthanoid Series Elements; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Water | 2003 |
Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging.
Topics: Animals; Bile Acids and Salts; Chelating Agents; Contrast Media; Female; Gadolinium; Hemodynamics; Hepatocytes; Heterocyclic Compounds, 1-Ring; Lethal Dose 50; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Organometallic Compounds; Pentetic Acid; Rabbits; Rats | 2004 |
Complexing mechanism of the lanthanide cations Eu3+, Gd3+, and Tb3+ with 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (dota)-characterization of three successive complexing phases: study of the thermodynamic and structural properties of
Topics: Cations; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Hydrogen-Ion Concentration; Luminescent Measurements; Molecular Structure; Potentiometry; Protons; Solutions; Spectrum Analysis; Terbium; Thermodynamics | 2004 |
Synthesis of a bifunctional monophosphinic acid DOTA analogue ligand and its lanthanide(III) complexes. A gadolinium(III) complex endowed with an optimal water exchange rate for MRI applications.
Topics: Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Ligands; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Molecular Structure; Organometallic Compounds; Oxygen Isotopes; Phosphinic Acids; Protons; Reference Standards; Temperature; Water | 2005 |
Dendrimeric Gd(III) complex of a monophosphinated DOTA analogue: optimizing relaxivity by reducing internal motion.
Topics: Dendrimers; Gadolinium; Heterocyclic Compounds, 1-Ring; Molecular Structure; Organometallic Compounds; Polyamines | 2005 |
Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
Topics: Animals; Brain Mapping; Brain Neoplasms; Cell Line, Tumor; Gadolinium; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mass Spectrometry; Neoplasm Transplantation; Neutron Capture Therapy; Pentetic Acid; Radiography; Radioisotopes; Radionuclide Imaging; Rats; Time Factors; Tissue Distribution | 2005 |
A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting.
Topics: Adsorption; Amides; Binding, Competitive; Biocompatible Materials; Bone and Bones; Chelating Agents; Diphosphonates; Durapatite; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Biological; Molecular Structure | 2005 |
Relaxometric and solution NMR structural studies on ditopic lanthanide(III) complexes of a phosphinate analogue of DOTA with a fast rate of water exchange.
Topics: Benzene Derivatives; Chelating Agents; Dysprosium; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Organometallic Compounds; Phosphinic Acids; Yttrium | 2006 |
A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles.
Topics: Chelating Agents; Contrast Media; Electron Spin Resonance Spectroscopy; Freezing; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds, 1-Ring; Ligands; Magnetic Resonance Spectroscopy; Models, Chemical; Organometallic Compounds; Solutions | 2006 |
In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes.
Topics: Animals; Carrier Proteins; Cell Line, Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Glutamine; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasms, Experimental; Organometallic Compounds; Rats; Receptor, ErbB-2; Transplantation, Heterologous | 2006 |
Long-range-distance NMR effects in a protein labeled with a lanthanide-DOTA chelate.
Topics: Chelating Agents; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Magnetic Resonance Spectroscopy; Molecular Structure; Proteins; Staining and Labeling | 2007 |
Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphonates; Solutions; Water | 2007 |
Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pH.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Potentiometry; Titrimetry; Water | 2007 |
Plasma clearance of bacteriophage Qbeta particles as a function of surface charge.
Topics: Animals; Azides; Bacteriophages; Capsid; Gadolinium; Heterocyclic Compounds, 1-Ring; Liver; Mice; Mice, Inbred BALB C; Models, Genetic; Models, Molecular; Molecular Conformation; Nanoparticles; Spectrophotometry; Surface Properties | 2008 |
Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy.
Topics: Amides; Animals; Bone and Bones; Chelating Agents; Diphosphonates; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanum; Ligands; Lutetium; Male; Radioisotopes; Radionuclide Imaging; Rats; Rats, Inbred Lew; Structure-Activity Relationship; Tissue Distribution | 2008 |
Pyridine-N-oxide analogues of DOTA and their gadolinium(III) complexes endowed with a fast water exchange on the square-antiprismatic isomer.
Topics: Carboxylic Acids; Dendrimers; Gadolinium; Heterocyclic Compounds, 1-Ring; Isomerism; Ligands; Luminescent Measurements; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pyridines; Time Factors; Water | 2009 |
Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents.
Topics: Animals; Colonic Neoplasms; Contrast Media; Drug Carriers; Female; Gadolinium; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Mice; Micelles; Neoplasm Transplantation; Polyethylene Glycols; Polylysine; Tissue Distribution | 2009 |
Gd(iii) complex of a monophosphinate-bis(phosphonate) DOTA analogue with a high relaxivity; Lanthanide(iii) complexes for imaging and radiotherapy of calcified tissues.
Topics: Bone and Bones; Calcinosis; Chelating Agents; Contrast Media; Crystallography, X-Ray; Diagnostic Imaging; Durapatite; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Molecular Structure; Organophosphonates; Radiography | 2009 |
A new bifunctional Gd(III) complex of enhanced efficacy for MR-molecular imaging applications.
Topics: Contrast Media; Coordination Complexes; Drug Design; Gadolinium; Heterocyclic Compounds, 1-Ring; Image Enhancement; Ligands; Magnetic Resonance Imaging | 2009 |
Magnetic resonance imaging of human glioma cells by means of an interleukin-6 receptor-targeted contrast agent.
Topics: Cell Line, Tumor; Contrast Media; Coordination Complexes; Fluorescent Dyes; Gadolinium; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Magnetic Resonance Imaging; Receptors, Interleukin-6; Rhodamines | 2010 |
Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the Gd(III) chelates.
Topics: Chelating Agents; Gadolinium; Heterocyclic Compounds, 1-Ring; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Lipids; Liposomes; Magnetics; Micelles; Models, Molecular; Molecular Conformation; Motion; Nanoparticles; Organometallic Compounds | 2010 |
Synthesis and characterization of dinuclear heterometallic lanthanide complexes exhibiting MRI and luminescence response.
Topics: Acetates; Chelating Agents; Contrast Media; Coordination Complexes; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Ligands; Magnetic Resonance Imaging; Spectrometry, Fluorescence; Terbium | 2010 |
Design, synthesis, and evaluation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derived, redox-sensitive contrast agents for magnetic resonance imaging.
Topics: Binding, Competitive; Contrast Media; Coordination Complexes; Crystallography, X-Ray; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Models, Molecular; Molecular Structure; Protein Binding; Serum Albumin; Structure-Activity Relationship | 2010 |
Gd-complexes of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-1,4,7,10-tetraacetic acid (DOTA) conjugates of tranexamates as a new class of blood-pool magnetic resonance imaging contrast agents.
Topics: Animals; Blood; Cell Line; Contrast Media; Coordination Complexes; Esters; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Liver; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Organ Specificity; Structure-Activity Relationship; Tranexamic Acid | 2011 |
A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
Topics: Animals; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Materials Testing; Mice; Nanoparticles; Particle Size; Sensitivity and Specificity | 2011 |
Synthesis and characterization of a theranostic vascular disrupting agent for in vivo MR imaging.
Topics: Cell Death; Colchicine; Dose-Response Relationship, Drug; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Molecular Conformation; Stereoisomerism; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
A smart magnetic resonance imaging contrast agent responsive to adenosine based on a DNA aptamer-conjugated gadolinium complex.
Topics: Adenosine; Aptamers, Nucleotide; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Protein Binding; Streptavidin | 2011 |
Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4.
Topics: Animals; Binding Sites; Chelating Agents; Coordination Complexes; Dimerization; Drug Design; Gadolinium; Heterocyclic Compounds, 1-Ring; Ligands; Mice; Mice, Nude; Models, Molecular; Oligopeptides; Peptides, Cyclic; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Receptors, CXCR4; Structure-Activity Relationship; Tissue Distribution | 2011 |
Synthesis of PECAM-1-specific 64Cu PET imaging agent: evaluation of myocardial infarction caused by ischemia-reperfusion injury in mouse.
Topics: Animals; Antibodies; Chromatography, High Pressure Liquid; Copper Radioisotopes; Gadolinium; Gene Expression; Heterocyclic Compounds, 1-Ring; Immunoconjugates; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Radioimmunoassay; Radiopharmaceuticals; Staining and Labeling; Tissue Distribution | 2012 |
Structural analysis of isomeric europium(III) chelates of NB-DOTMA.
Topics: Chelating Agents; Contrast Media; Coordination Complexes; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Stereoisomerism; Water | 2012 |
Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields.
Topics: Contrast Media; Coordination Complexes; Cyclodextrins; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Magnetic Fields; Magnetic Resonance Imaging | 2012 |
High signal contrast gating with biomodified Gd doped mesoporous nanoparticles.
Topics: Gadolinium; Heterocyclic Compounds, 1-Ring; Metal Nanoparticles; Porosity; Proteins; Silicon Dioxide; Water | 2013 |
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
Topics: Amino Acid Sequence; Animals; Brain; Contrast Media; Coordination Complexes; Gadolinium; Heterocyclic Compounds, 1-Ring; Inflammation; Ions; Leukocytes; Magnetic Resonance Imaging; Mice; Oligopeptides; Protein Binding; Radiography; Receptors, Formyl Peptide | 2013 |
MRI visualization of melanoma cells by targeting overexpressed sialic acid with a Gd(III)-dota-en-pba imaging reporter.
Topics: Animals; Contrast Media; Coordination Complexes; Gadolinium; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Melanoma, Experimental; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Radiography; Transplantation, Homologous | 2013 |
Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity.
Topics: Chelating Agents; Contrast Media; Coordination Complexes; Gadolinium; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Nanoparticles; Porosity; Silicon Dioxide | 2013 |
Dual-labeled glycoclusters: synthesis and their application in monitoring lectin-mediated endocytosis.
Topics: Asialoglycoprotein Receptor; Asialoglycoproteins; Cell Membrane; Endocytosis; Fluorescent Dyes; Gadolinium; Glycoproteins; Hep G2 Cells; Heterocyclic Compounds, 1-Ring; Humans; Lectins; Magnetic Resonance Imaging; Microscopy, Confocal; Models, Chemical; Molecular Structure; Protein Binding; Reproducibility of Results; Rhodamines; Staining and Labeling | 2013 |
Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent.
Topics: Aniline Compounds; Animals; Benzothiazoles; Blood-Brain Barrier; Brain; Contrast Media; Coordination Complexes; Drug Stability; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Radionuclide Imaging; Technetium; Tissue Distribution | 2013 |
cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).
Topics: Animals; Cell Line, Tumor; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Male; Mice; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Peptides, Cyclic; Prostatic Neoplasms; Vitamin B 12 | 2013 |
Orthogonal spin labeling and Gd(III)-nitroxide distance measurements on bacteriophage T4-lysozyme.
Topics: Bacteriophage T4; Electron Spin Resonance Spectroscopy; Electrons; Gadolinium; Heterocyclic Compounds, 1-Ring; Muramidase; Mutation; Nitrogen Oxides; Spin Labels | 2013 |
In vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticles.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Isotope Labeling; Knee Joint; Nanoparticles; Neoplasms; Proteoglycans; Pyridinium Compounds; Quantum Dots; Quaternary Ammonium Compounds; Radionuclide Imaging; Rats | 2013 |
Synthesis of a DOTA (Gd3+)-conjugate of proton-pump inhibitor pantoprazole for gastric wall imaging studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Contrast Media; Coordination Complexes; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Pantoprazole; Proton Pump Inhibitors; Radiography; Stomach; Temperature | 2013 |
A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates.
Topics: Chelating Agents; Copper; Cyclams; Gadolinium; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Ligands; Lutetium; Molecular Structure; Peptides; Peptides, Cyclic; Phosphinic Acids; Polyethylene Glycols; Radiopharmaceuticals; Thermodynamics; Yttrium | 2013 |
Convenient synthesis of (68)Ga-labeled gadolinium(III) complexes: towards bimodal responsive probes for functional imaging with PET/MRI.
Topics: Animals; Contrast Media; Coordination Complexes; Gadolinium; Heterocyclic Compounds, 1-Ring; Kidney; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Rats; Rats, Wistar | 2013 |
Highly water-dispersible surface-modified Gd(2)O(3) nanoparticles for potential dual-modal bioimaging.
Topics: Cell Survival; Contrast Media; Europium; Gadolinium; HeLa Cells; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Microscopy, Confocal; Surface Properties; Water | 2013 |
The gastrin/cholecystokinin-B receptor on prostate cells--a novel target for bifunctional prostate cancer imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Fluorescent Dyes; Gadolinium; Gastrins; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Oligopeptides; Prostate; Prostatic Neoplasms; Receptor, Cholecystokinin B; Rhodamines | 2014 |
Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experiments.
Topics: Animals; Binding Sites; Contrast Media; Coordination Complexes; Crystallography, X-Ray; Gadolinium; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Mice; Mice, Nude; Molecular Docking Simulation; Neoplasms; Neurotensin; Positron-Emission Tomography; Protein Structure, Tertiary; Receptors, Neurotensin; Tissue Distribution; Transplantation, Heterologous | 2013 |
Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents.
Topics: Albumins; Animals; Chelating Agents; Contrast Media; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Ibuprofen; Kinetics; Magnetic Resonance Imaging; Mice; Protein Binding; Water | 2014 |
Redox-triggered self-assembly of gadolinium-based MRI probes for sensing reducing environment.
Topics: Gadolinium; Glutathione; HeLa Cells; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Oxidation-Reduction | 2014 |
Integrin α2β1 targeted GdVO4:Eu ultrathin nanosheet for multimodal PET/MR imaging.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell Survival; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Integrin alpha2beta1; Magnetic Resonance Imaging; Male; Mice, Nude; Multimodal Imaging; Nanoparticles; Oleic Acid; Oligopeptides; Positron-Emission Tomography; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Tissue Distribution; Vanadates; X-Ray Diffraction; Xenograft Model Antitumor Assays | 2014 |
Templated assembly of albumin-based nanoparticles for simultaneous gene silencing and magnetic resonance imaging.
Topics: Cell Line, Tumor; Endocytosis; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Nanoparticles; Nanotechnology; Porosity; RNA Interference; RNA, Small Interfering; Serum Albumin; Silicon Dioxide | 2014 |
Cellular Uptake and Photo-Cytotoxicity of a Gadolinium(III)-DOTA-Naphthalimide Complex "Clicked" to a Lipidated Tat Peptide.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Click Chemistry; Coordination Complexes; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Naphthalimides; Photosensitizing Agents; tat Gene Products, Human Immunodeficiency Virus | 2016 |
Towards an MMP-2-activated molecular agent for cancer imaging.
Topics: Amino Acid Sequence; Enzyme Activation; Gadolinium; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Matrix Metalloproteinase 2; Neoplasms; Organometallic Compounds; Peptides | 2018 |
Preoperative Examination and Intraoperative Identification of Hepatocellular Carcinoma Using a Targeted Bimodal Imaging Probe.
Topics: Animals; Carcinoma, Hepatocellular; Coloring Agents; Contrast Media; Gadolinium; Hep G2 Cells; Heterocyclic Compounds, 1-Ring; Humans; Infrared Rays; Liver Neoplasms; Magnetic Resonance Imaging; Mice, Inbred BALB C; Mice, Nude; Optical Imaging; Peptides; Preoperative Period | 2018 |
Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis.
Topics: Animals; Cell Line, Tumor; Cell Survival; Contrast Media; Coordination Complexes; Dendrimers; Gadolinium; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Melanoma, Experimental; Metal Nanoparticles; Mice; Oligopeptides; RAW 264.7 Cells; Signal-To-Noise Ratio; Tomography, X-Ray Computed; Transplantation, Homologous | 2019 |
Gadolinium-based MRI contrast agent for the detection of tyrosinase.
Topics: Contrast Media; Enzyme Assays; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Limit of Detection; Magnetic Resonance Imaging; Molecular Probes; Monophenol Monooxygenase | 2020 |
Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets.
Topics: Adult; Blood Platelets; Cells, Cultured; Contrast Media; Cross-Linking Reagents; Dextrans; Emulsions; Gadolinium; Healthy Volunteers; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Human Umbilical Vein Endothelial Cells; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Nanoparticles; Organometallic Compounds; Particle Size; Platelet Activation; Polysaccharides; Spectrometry, X-Ray Emission; Thrombosis | 2020 |
Long story short: donor set symmetry in [Eu(DOTA)(H
Topics: Contrast Media; Electronics; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Ions; Lanthanoid Series Elements; Ligands; Luminescent Agents | 2022 |